Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Understanding the differences between budgeting methods can help you choose the best approach. See how zero based budgeting stacks up.
22,683 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Meta Platforms looks cheaper than it has in years, with growth signals that could power a turnaround by 2027. This gu...
S&P Global Ratings keeps the U.S. sovereign rating at AA+ with a stable outlook, citing economic resilience despite p...
Gold has long been a steadying force in volatile markets. This article presents a practical, balanced way to approach...
A 2025 financial filing shows Donald Trump collected a SAG-AFTRA pension of $77,808, underscoring how vested retireme...
Netflix has fallen sharply, but a trough like this can hide opportunity. This guide breaks down what drove the declin...
Microsoft shifts core apps to its MAI system, pressuring margins while Google leans on in‑house silicon and Gemini. A...
As mid-2026 trading picks up, McDonald’s demonstrates stronger growth and cash flow versus Pfizer, which relies on in...
A Brooklyn rehab clinic case has public officials chasing a suspected scam spanning years. This article breaks down w...
Zillow, MRED and Compass exchanged new briefs after a two-day hearing on Chicagoland data access, intensifying an ant...
A new paid service promises ultra-fast access to high-profile Truth Social posts, including those from President Trum...
AI-driven demand is reshaping chip markets, but selecting the right names matters. This guide highlights five semicon...